GLP-1 Receptor Agonist Market is Expected to be Flourished by Growing Adoption of Therapeutics to Treat Diabetes
by GLP-1 receptor agonists (also known as incretin mimetics) are a class of drugs used to treat type 2 diabetes. They work by mimicking the effects …